99470-00-5

Basic information

• Product Name: 2-(3-methoxy-4-(methoxycarbonyl)phenyl)aceticacid
• Synonyms: 2-(3-methoxy-4-(methoxycarbonyl)phenyl)aceticacid;(2-methoxy-4-methoxycarbonyl-phneyl)-acetic acid;Benzeneacetic acid, 3-methoxy-4-(methoxycarbonyl)-;[3-methoxy-4-(methoxycarbonyl)phenyl]acetic acid
• CAS NO: 99470-00-5
• Molecular Formula: C₁₁H₁₂O₅
• Molecular Weight: 224.20998
• Mol File: 99470-00-5.mol
• Article Data: 2

Chemical Properties

• Boiling Point: 394.6±32.0 °C(Predicted)
• Appearance: /
• Density: 1.254±0.06 g/cm3(Predicted)
• PKA: 3.95±0.10(Predicted)
• CAS DataBase Reference: 2-(3-methoxy-4-(methoxycarbonyl)phenyl)aceticacid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-methoxy-4-(methoxycarbonyl)phenyl)aceticacid(99470-00-5)
• EPA Substance Registry System: 2-(3-methoxy-4-(methoxycarbonyl)phenyl)aceticacid(99470-00-5)

Safety Data

• Hazardous Substances Data: 99470-00-5(Hazardous Substances Data)

Usage

Structure

A phenylacetic acid derivative containing a benzene ring with two methoxy groups and one carboxyl group attached

Usage

Building block in organic synthesis and pharmaceutical research for the production of various pharmaceutical drugs and natural products

Potential applications

Medicine, agriculture, and materials science

Safety precautions

Handle and store with proper safety measures to avoid health hazards upon exposure

Upstream product

• 124-38-9 carbon dioxide 
• 92288-31-8 methyl 4-cyanomethyl-2-methoxy-benzoate 
• 219922-37-9 methyl 4-aminocarbonylmethyl-2-methoxy-benzoate 

Downstream Products

• 219922-20-0 methyl 2-methoxy-4-<2-<<1-<2-(1-piperidinyl)phenyl>butyl>amino>-2-oxoethyl>-benzoate 
• 808133-95-1 methyl 5-bromo-4-carboxymethyl-2-methoxy-benzoate 
• 99469-92-8 methyl 2-methoxy-4-[N-(α-phenyl-2-piperidino-benzyl)aminocarbonylmethyl]-benzoate 
• 957826-12-9 methyl 5-chloro-4-carboxymethyl-2-methoxy-benzoate 

Relevant articles and documents

INHIBITORS OF PAPILLOMA VIRUS

The use of a compound of formula (II): or its enantiomers or diastereoisomers thereof, or salts or pharmaceutically-acceptable esters thereof, in the treatment or prevention of a papilloma virus infection, particularly human papilloma virus in a mammal, wherein R11; X4; X5; X6; R13; R14; W; Z; Y; T; and R18 are defined herein. The present invention also provides novel compounds, pharmaceutical compositions and methods for using these compounds and compositions in the treatment or prevention of papilloma virus infection. More particularly, the present invention provides compounds, compositions and methods for inhibiting papilloma virus DNA replication by interfering with the E1-E2 protein-protein interaction essential for viral DNA replication.